During the past decade, Austin Heart conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 26 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 12 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Heart" #1 sponsor was "Abbott Medical Devices" with 17 trials, followed by "Edwards Lifesciences" with 8 trials sponsored, "Point Biomedical" with 5 trials sponsored, "Ancora Heart, Inc." with 3 trials sponsored and "Avinger, Inc." with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Heart" #1 collaborator was "Abbott" with 3 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "American College of Cardiology" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Austin Heart" are "Coronary Artery Disease" (15 trials), "Heart Failure" (9 trials), "Atrial Fibrillation" (7 trials), "Aortic Stenosis" (4 trials) and "Myocardial Infarction" (4 trials). Many other conditions were trialed in "Austin Heart" in a lesser frequency.

Most popular intervention types in "Austin Heart" are "Device" (46 trials), "Drug" (23 trials), "Procedure" (8 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "A-002" (2 trials), "Coronary PCI guided by Angiography" (2 trials), "Coronary PCI guided by OCT" (2 trials) and "PB127 for Injectable Suspension" (2 trials). Other intervention names were less common.

The vast majority of trials in "Austin Heart" are 70 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Austin Heart". undefined are not yet recruiting, 9 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Austin Heart, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Heart, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 39 trials that are defined as “Not Applicable".

Austin Heart has several departments that took part in Clinical trials: "Austin Heart Clinical Research" - 2 trials